The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-24

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infections.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Home Testing of Respiratory Illness

NCT04245800

Influenza -Like Illness Influenza A Influenza Type B +2 more

COMPLETED

Assessment of Wearable Sensors During Experimental Human Influenza Infection (Sigma Plus)

NCT04204993

Influenza A H3N2

COMPLETED NA

Infection Watch Study

NCT04623047

COVID-19 Respiratory Infection Respiratory Syncytial Virus Infections Rhinoviral Infections +1 more

COMPLETED

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections

NCT05290792

Viral Respiratory Tract Infection Influenza

COMPLETED NA

Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19

NCT04912895

Covid19

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be configured in CareEvolution's myDataHelps platform. This app-based platform will allow people to:

* Provide informed consent electronically
* Donate robust smartwatch and activity tracker data, as well as self-reported data.
* Sensor-collected data, which will vary between devices, but what is shared will always be entirely up to the participant. Investigators anticipate a minimum to include heart rate and activity, plus sleep duration when available.

* This can include historical data collected by a sensor prior to the participants date of joining the study.
* Occasional survey-based participant-reported outcomes (PROs).
* Participant-entered physiologic data such as oral temperature
* Passively share environmental data such as air quality and weather that will be captured from external sources based on participants' "home" zip code. Optionally, if the participant consents to enable location/GPS services on their smartphone, higher grain environmental data will be enabled.
* Optionally connect to and share their electronic health record (EHR) data in the event they have an event that requires interaction with a health care provider

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Influenza Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Living in the U.S.
* 18 years or older
* Android or iPhone Smartphone user
* Any connected wearable (Apple Watch, Fitbit, Garmin watch connected to Apple Health or Google Fit, Amazfit)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No